Related Experiment Videos
Polymyxin B stimulates production of complement components and cytokines in human monocytes
1Department of Pediatric Research, Rikshospitalet, National Hospital, Oslo Norway.
Abstract:
Polymyxin B (PmB), an agent often used to neutralize the effects of bacterial lipopolysaccharide (LPS), was shown to exert a dose-dependent stimulatory effect on the biosynthesis of C3, factor B, interleukin-6 (IL-6), and granulocyte-macrophage colony-stimulating factor (GM-CSF) in human monocytes. A low dose of PmB (1 to 5 micrograms/ml) efficiently suppressed the LPS-induced (1 or 100 ng/ml) production of IL-6, GM-CSF, and factor B, but not the C3 production induced by 100 ng of LPS per ml. A reduced level of GM-CSF may have contributed to the persisting high C3 concentrations and the apparent lack of LPS inhibition in the latter situation, since GM-CSF is an inhibitor of monocyte C3 biosynthesis.
Insights
Polymyxin B (PmB) has a dual effect on human monocytes, stimulating certain factors at higher doses but suppressing lipopolysaccharide (LPS)-induced inflammation at lower doses. Low-dose PmB inhibited IL-6, GM-CSF, and factor B, but not C3, suggesting complex immune modulation.
Area of Science:
- Immunology
- Pharmacology
Background:
- Polymyxin B (PmB) is utilized to neutralize bacterial lipopolysaccharide (LPS).
- Human monocytes play a crucial role in innate and adaptive immunity, responding to microbial stimuli like LPS.
Purpose of the Study:
- To investigate the dose-dependent effects of Polymyxin B on the biosynthesis of complement components and cytokines in human monocytes.
- To determine the efficacy of low-dose Polymyxin B in suppressing LPS-induced inflammatory responses.
Main Methods:
- Human monocytes were treated with varying concentrations of Polymyxin B (PmB) and lipopolysaccharide (LPS).
- Biosynthesis of C3, factor B, interleukin-6 (IL-6), and granulocyte-macrophage colony-stimulating factor (GM-CSF) was measured.
- The impact of PmB on LPS-induced cytokine and complement production was analyzed.
Main Results:
- Polymyxin B demonstrated a dose-dependent stimulatory effect on C3, factor B, IL-6, and GM-CSF biosynthesis.
- Low-dose PmB (1-5 µg/ml) suppressed LPS-induced production of IL-6, GM-CSF, and factor B.
- However, low-dose PmB did not inhibit LPS-induced C3 production at 100 ng/ml.
- Reduced GM-CSF levels may explain the persistent high C3 concentrations, as GM-CSF inhibits monocyte C3 biosynthesis.
Conclusions:
- Polymyxin B exhibits complex immunomodulatory effects on human monocytes, with dose-dependent stimulatory and suppressive actions.
- Low-dose Polymyxin B can inhibit key inflammatory mediators induced by LPS, but its effect on C3 production is limited.
- These findings highlight the intricate interplay between PmB, LPS, and monocyte-derived factors in regulating immune responses.